OCULAR DRUG DELIVERY - PHARMACOKINETIC CONSIDERATIONS

被引：134
|
作者：
SCHOENWALD, RD
机构：
[1] University of Iowa. College of Pharmacy, Iowa City, Iowa
来源：
CLINICAL PHARMACOKINETICS | 1990年 / 18卷 / 04期
关键词：
D O I：
10.2165/00003088-199018040-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：255 / 269
页数：15
相关论文
共 50 条
  • [1] Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations
    Shen, Jie
    Lu, Guang Wei
    Hughes, Patrick
    PHARMACEUTICAL RESEARCH, 2018, 35 (11)
  • [2] Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations
    Jie Shen
    Guang Wei Lu
    Patrick Hughes
    Pharmaceutical Research, 2018, 35
  • [3] A pharmacokinetic model for ocular drug delivery
    Tojo, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (11) : 1290 - 1294
  • [4] Pharmacokinetic considerations for targeted drug delivery
    Yamashita, Fumiyoshi
    Hashida, Mitsuru
    ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 139 - 147
  • [5] Intravesical drug delivery - Pharmacokinetic and clinical considerations
    Highley, MS
    van Oosterom, AT
    Maes, RA
    De Bruijn, EA
    CLINICAL PHARMACOKINETICS, 1999, 37 (01) : 59 - 73
  • [6] PHARMACOKINETIC CONSIDERATIONS IN LOCAL-DRUG DELIVERY
    DAEMEN, MJAP
    THIJSSEN, HHW
    STRUYKERBOUDIER, HAJ
    ADVANCED DRUG DELIVERY REVIEWS, 1991, 6 (01) : 1 - 18
  • [7] TARGETED DRUG DELIVERY - SOME PHARMACOKINETIC CONSIDERATIONS
    LEVY, G
    PHARMACEUTICAL RESEARCH, 1987, 4 (01) : 3 - 4
  • [8] Considerations for Polymers Used in Ocular Drug Delivery
    Allyn, Megan M.
    Luo, Richard H.
    Hellwarth, Elle B.
    Swindle-Reilly, Katelyn E.
    FRONTIERS IN MEDICINE, 2022, 8
  • [9] Biopharmaceutical considerations in topical ocular drug delivery
    Davies, NM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (07) : 558 - 562
  • [10] Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
    Wassana Wijagkanalan
    Shigeru Kawakami
    Mitsuru Hashida
    Pharmaceutical Research, 2011, 28 : 1500 - 1519
12345